Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein-Ligand Complexes.
Nazare, M., Matter, H., Will, D.W., Wagner, M., Urmann, M., Czech, J., Schreuder, H., Bauer, A., Ritter, K., Wehner, V.(2012) Angew Chem Int Ed Engl 51: 905
- PubMed: 22190348 
- DOI: https://doi.org/10.1002/anie.201107091
- Primary Citation of Related Structures:  
4A7I
Organizational Affiliation: 
Sanofi-Aventis Deutschland GmbH, R&D, Industriepark Höchst, Building G878, 65926 Frankfurt am Main, Germany. marc.nazare@sanofi-aventis.com